McKesson (MCK) Financials

$720.88 -8.03 (-1.10%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$728.56 +7.68 (+1.07%)

As of 06/20/2025 07:57 PM Eastern

Annual Income Statements for McKesson

This table shows McKesson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2015	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Net Income / (Loss) Attributable to Common Shareholders	1,476	2,258	5,070	67	34	900	-4,539	1,114	3,560	3,002
Consolidated Net Income / (Loss)	1,543	2,310	5,153	297	255	1,120	-4,340	1,287	3,722	3,160
Net Income / (Loss) Continuing Operations	1,842	2,342	5,277	292	254	1,126	-4,339	1,292	3,725	3,160
Total Pre-Tax Income	2,657	3,250	6,891	239	610	1,144	-5,034	1,928	4,630	3,789
Total Operating Income	2,968	3,545	7,122	762	886	2,489	-5,040	2,038	4,381	3,909
Total Gross Profit	11,411	11,416	11,271	11,184	11,754	12,023	12,148	13,130	12,358	12,828
Total Revenue	179,045	190,884	198,533	208,357	214,319	231,051	238,228	263,966	276,711	308,951
Operating Revenue	179,045	190,884	198,533	208,357	214,319	231,051	238,228	263,966	276,711	308,951
Total Cost of Revenue	167,634	179,468	187,262	197,173	202,565	219,028	226,080	250,836	264,353	296,123
Operating Cost of Revenue	167,634	179,468	187,262	197,173	202,565	219,028	226,080	250,836	264,353	296,123
Total Operating Expenses	8,443	7,871	4,149	10,422	10,868	9,534	17,188	11,092	7,977	8,919
Selling, General & Admin Expense	7,901	7,379	7,447	8,138	8,437	9,182	8,849	10,537	7,776	8,657
Restructuring Charge	0.00	203	18	567	597	268	334	281	209	115
Other Special Charges / (Income)	150	-	0.00	-146	37	82	7,936	274	-8.00	147
Total Other Income / (Expense), net	-311	-295	-231	-523	-276	-1,345	6.00	-110	249	-120
Interest Expense	374	353	308	405	264	249	217	369	248	252
Other Income / (Expense), net	63	58	77	-118	182	12	223	259	497	132
Income Tax Expense	815	908	1,614	-53	356	18	-695	636	905	629
Net Income / (Loss) Discontinued Operations	-299	-32	-124	5.00	1.00	-6.00	-1.00	-5.00	-3.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	67	52	83	230	221	220	199	173	162	158
Basic Earnings per Share	$6.37	$9.82	$22.95	$0.32	$0.17	$4.98	($28.26)	$7.32	$25.23	$22.54
Weighted Average Basic Shares Outstanding	232M	230M	221M	208M	196.30M	180.60M	160.60M	152.30M	141.10M	133.20M
Diluted Earnings per Share	$6.27	$9.70	$22.73	$0.32	$0.17	$4.95	($28.26)	$7.23	$25.03	$22.39
Weighted Average Diluted Shares Outstanding	235M	233M	223M	209M	197.30M	181.60M	160.60M	154.10M	142.20M	134.10M
Weighted Average Basic & Diluted Shares Outstanding	231.70M	229.90M	220.90M	209.40M	200M	161.85M	158.19M	145.37M	135.60M	129.99M
Cash Dividends to Common per Share	$0.96	$1.08	$1.12	$1.30	$1.51	$1.62	$1.67	$1.83	$2.09	$2.40

This table shows McKesson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	768	926	1,079	787	958	664	589	791	915	241	879
Consolidated Net Income / (Loss)	809	967	1,120	826	997	703	630	830	960	287	928
Net Income / (Loss) Continuing Operations	807	973	1,119	826	997	703	630	830	960	287	928
Total Pre-Tax Income	1,006	1,244	1,448	932	1,091	916	612	1,170	1,084	534	1,226
Total Operating Income	1,036	1,124	1,241	980	1,100	951	642	1,216	1,029	578	1,224
Total Gross Profit	3,023	3,095	3,174	3,066	3,022	3,069	3,152	3,585	3,152	3,248	3,284
Total Revenue	67,154	70,157	70,490	68,910	74,483	77,215	80,898	76,355	79,283	93,651	95,294
Operating Revenue	67,154	70,157	70,490	68,910	74,483	77,215	80,898	76,355	79,283	93,651	95,294
Total Cost of Revenue	64,131	67,062	67,316	65,844	71,461	74,146	77,746	72,770	76,131	90,403	92,010
Operating Cost of Revenue	64,131	67,062	67,316	65,844	71,461	74,146	77,746	72,770	76,131	90,403	92,010
Total Operating Expenses	1,987	1,971	1,933	2,086	1,922	2,118	2,510	2,369	2,123	2,670	2,060
Selling, General & Admin Expense	1,959	1,950	1,903	1,964	1,870	2,092	2,506	2,189	2,001	2,503	2,028
Restructuring Charge	23	30	31	125	52	28	4.00	31	10	171	32
Other Special Charges / (Income)	5.00	-9.00	-1.00	-3.00	0.00	-2.00	0.00	149	112	-4.00	0.00
Total Other Income / (Expense), net	-30	120	207	-48	-9.00	-35	-30	-46	55	-44	2.00
Interest Expense	45	55	69	79	47	61	64	80	75	78	67
Other Income / (Expense), net	15	175	276	31	38	26	34	34	130	34	69
Income Tax Expense	199	271	329	106	94	213	-18	340	124	247	298
Net Income / (Loss) Attributable to Noncontrolling Interest	41	41	41	39	39	39	41	39	45	46	49
Basic Earnings per Share	$5.32	$6.47	$7.71	$5.73	$7.07	$4.95	$4.45	$6.07	$7.04	$1.88	$6.98
Weighted Average Basic Shares Outstanding	144.20M	143.10M	139.90M	141.10M	135.50M	134.10M	132.50M	133.20M	129.80M	128.70M	126M
Diluted Earnings per Share	$5.26	$6.42	$7.66	$5.69	$7.02	$4.92	$4.42	$6.03	$7.00	$1.87	$6.95
Weighted Average Diluted Shares Outstanding	145.90M	144.10M	141M	142.20M	136.60M	134.80M	133.30M	134.10M	130.70M	129.30M	126.60M
Weighted Average Basic & Diluted Shares Outstanding	143.73M	141.79M	136.94M	135.60M	134.90M	133.06M	131.41M	129.99M	129.68M	126.94M	125.33M
Cash Dividends to Common per Share	$0.47	$0.54	$0.54	$0.54	$0.54	$0.62	$0.62	$0.62	$0.62	$0.71	$0.71

This table details how cash moves in and out of McKesson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2015	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Net Change in Cash & Equivalents	1,148	-1,293	-594	-1,732	309	1,042	2,373	-2,461	744	-94
Net Cash From Operating Activities	3,112	3,672	4,744	4,345	4,036	4,374	4,542	4,434	5,159	4,314
Net Cash From Continuing Operating Activities	3,112	3,672	4,744	4,345	4,036	4,374	4,542	4,434	5,159	4,314
Net Income / (Loss) Continuing Operations	1,543	2,310	5,153	297	255	1,120	-4,340	1,287	3,722	3,160
Consolidated Net Income / (Loss)	1,543	2,310	5,153	297	255	1,120	-4,340	1,287	3,722	3,160
Depreciation Expense	306	281	324	303	317	321	321	279	248	253
Amortization Expense	711	604	586	648	632	601	566	481	360	382
Non-Cash Adjustments To Reconcile Net Income	799	380	-3,517	2,227	2,029	1,985	717	2,271	409	1,149
Changes in Operating Assets and Liabilities, net	-247	97	2,198	870	803	347	7,278	116	420	-630
Net Cash From Investing Activities	-677	-1,557	-3,269	-2,993	-1,381	-579	-415	-89	-542	-1,072
Net Cash From Continuing Investing Activities	-677	-1,767	-3,269	-2,993	-1,381	-579	-415	-89	-542	-1,072
Purchase of Property, Plant & Equipment	-376	-488	-404	-405	-426	-362	-451	-388	-390	-431
Acquisitions	-339	-229	-4,370	-3,068	-1,036	-277	-225	-153	-1,035	-528
Divestitures	15	0.00	206	500	101	37	400	578	1,077	47
Other Investing Activities, net	23	-1,050	1,299	-20	-20	23	-139	-126	-194	-160
Net Cash From Financing Activities	-968	-3,453	-2,069	-3,084	-2,227	-2,734	-1,693	-6,321	-4,368	-3,342
Net Cash From Continuing Financing Activities	-968	-3,453	-2,069	-3,084	-2,227	-2,734	-1,693	-6,321	-4,368	-3,342
Repayment of Debt	-3,546	-3,281	-9,743	-23,309	-38,735	-22,053	-7,541	-13,407	-10,048	-20,427
Repurchase of Common Equity	-450	-1,612	-2,311	-1,709	-1,639	-1,937	-791	-4,547	-3,638	-3,025
Payment of Dividends	-227	-244	-253	-262	-292	-294	-276	-277	-292	-314
Issuance of Debt	3,103	1,561	10,118	22,064	38,364	21,437	6,823	11,690	9,447	20,955
Issuance of Common Equity	152	123	120	132	75	113	92	220	163	116
Other Financing Activities, net	-	-	-	-	-	-	-	0.00	0.00	-647
Effect of Exchange Rate Changes	-319	45	-	-	-119	-19	-61	55	25	6.00
Other Net Changes in Cash	-	-	-	-	-	-	0.00	-540	470	0.00
Cash Interest Paid	359	337	315	298	383	235	220	186	224	234
Cash Income Taxes Paid	866	923	587	144	262	368	379	359	562	901

This table details how cash moves in and out of McKesson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-1,595	618	-180	1,901	-2,042	-113	-541	2,602	-2,281	207	-1,229
Net Cash From Operating Activities	-941	1,107	1,668	3,325	-1,052	965	254	4,147	-1,380	2,100	-2,383
Net Cash From Continuing Operating Activities	-941	1,107	1,668	3,325	-1,052	965	254	4,147	-1,380	2,100	-2,383
Net Income / (Loss) Continuing Operations	809	967	1,120	826	997	703	630	830	960	287	928
Consolidated Net Income / (Loss)	809	967	1,120	826	997	703	630	830	960	287	928
Depreciation Expense	61	63	61	63	64	65	62	62	63	61	58
Amortization Expense	87	88	87	98	95	92	97	98	106	102	95
Non-Cash Adjustments To Reconcile Net Income	139	-64	96	238	140	395	668	-54	56	683	246
Changes in Operating Assets and Liabilities, net	-2,037	53	304	2,100	-2,348	-290	-1,203	3,211	-2,565	967	-3,710
Net Cash From Investing Activities	39	77	-414	-244	-149	-166	-180	-577	-87	-286	-136
Net Cash From Continuing Investing Activities	39	77	-414	-244	-149	-166	-180	-577	-87	-286	-136
Purchase of Property, Plant & Equipment	-71	-86	-108	-125	-78	-75	-90	-188	-106	-136	-126
Acquisitions	-30	-58	-879	-68	-46	-65	-70	-347	-61	-83	-72
Divestitures	240	256	578	3.00	39	11	-3.00	-	90	3.00	-10
Other Investing Activities, net	-100	-35	-5.00	-54	-64	-37	-17	-42	-10	-70	72
Net Cash From Financing Activities	-1,181	-572	-1,425	-1,190	-843	-909	-622	-968	-809	-1,599	1,298
Net Cash From Continuing Financing Activities	-1,181	-572	-1,425	-1,190	-843	-909	-622	-968	-809	-1,599	1,298
Repayment of Debt	-201	-156	-847	-8,844	-509	-1,987	-2,488	-15,443	-1,583	-6,072	-2,321
Repurchase of Common Equity	-1,000	-484	-2,016	-138	-696	-809	-842	-678	-527	-1,492	-827
Payment of Dividends	-71	-68	-77	-76	-74	-75	-83	-82	-82	-80	-92
Issuance of Debt	0.00	100	1,499	7,848	1,056	1,935	2,770	15,194	1,361	6,013	4,519
Issuance of Common Equity	91	36	16	20	27	27	21	41	22	32	19
Effect of Exchange Rate Changes	18	6.00	-9.00	10	2.00	-3.00	7.00	-	-5.00	6.00	-22

This table presents McKesson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2015	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Total Assets	53,870	56,523	60,969	60,381	59,672	61,247	65,015	63,298	62,320	67,443
Total Current Assets	36,670	38,435	36,948	37,136	38,465	42,222	45,382	46,231	44,292	47,970
Cash & Equivalents	5,341	4,048	2,783	2,672	2,981	4,015	6,278	3,532	4,678	4,583
Accounts Receivable	15,914	17,980	18,215	17,711	18,246	19,950	19,181	18,583	19,410	21,622
Inventories, net	14,296	15,335	15,278	16,310	16,709	16,734	19,246	18,702	19,691	21,139
Prepaid Expenses	1,119	1,072	672	443	529	617	665	898	513	626
Plant, Property, & Equipment, net	2,045	2,278	2,292	2,464	2,548	2,365	2,581	2,092	2,177	2,316
Total Noncurrent Assets	15,155	15,810	21,729	20,781	18,659	16,660	17,052	14,975	15,851	17,157
Goodwill	9,817	9,786	10,586	10,924	9,358	9,360	9,493	9,451	9,947	10,132
Intangible Assets	3,441	3,021	3,665	4,102	3,689	3,156	2,878	2,059	2,277	2,110
Other Noncurrent Operating Assets	1,897	3,003	3,415	2,027	2,099	4,144	4,681	3,465	3,627	4,915
Total Liabilities & Shareholders' Equity	53,870	56,523	60,969	60,381	59,672	61,247	65,015	63,298	62,320	67,443
Total Liabilities	44,399	46,109	48,369	48,865	49,992	54,536	63,569	65,090	63,810	69,042
Total Current Liabilities	33,497	35,069	35,612	36,685	37,626	42,624	44,103	48,466	47,957	52,357
Short-Term Debt	1,664	1,617	1,240	1,129	330	1,052	742	799	968	50
Accounts Payable	25,166	28,585	31,022	32,177	33,853	37,195	38,975	38,086	42,490	47,097
Accrued Expenses	3,769	3,948	3,004	3,379	3,443	3,340	3,987	4,543	4,200	4,915
Other Current Liabilities	-	-	-	-	-	354	390	297	299	295
Total Noncurrent Liabilities	10,902	11,040	12,757	12,180	12,366	11,912	19,466	16,624	15,853	16,685
Long-Term Debt	8,180	6,497	7,305	6,751	7,265	6,335	6,406	5,080	4,626	5,579
Asset Retirement Reserve & Litigation Obligation	-	-	-	-	-	0.00	8,067	7,220	6,625	6,113
Noncurrent Deferred & Payable Income Tax Liabilities	859	2,734	3,678	2,804	2,998	2,255	1,411	1,418	1,387	917
Other Noncurrent Operating Liabilities	1,863	1,809	1,774	2,625	2,103	3,322	3,582	2,906	3,215	4,076
Total Equity & Noncontrolling Interests	8,085	9,008	11,273	10,057	8,287	5,309	175	-1,792	-1,490	-1,599
Total Preferred & Common Equity	8,001	8,924	11,095	9,804	8,094	5,092	-21	-2,272	-1,857	-1,971
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	8,001	8,924	11,095	9,804	8,094	5,092	-21	-2,272	-1,857	-1,971
Common Stock	6,972	5,848	6,031	6,191	6,438	6,665	6,927	7,277	7,750	8,051
Retained Earnings	12,705	8,360	13,189	12,986	12,409	13,022	8,202	9,030	12,295	14,978
Treasury Stock	-9,956	-3,721	-5,982	-7,655	-8,902	-12,892	-13,670	-17,045	-20,997	-24,119
Accumulated Other Comprehensive Income / (Loss)	-1,713	-1,561	-2,141	-1,717	-1,849	-1,703	-1,480	-1,534	-905	-881
Noncontrolling Interest	84	84	178	253	193	217	196	480	367	372

This table presents McKesson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	62,295	63,081	62,690	62,320	64,096	66,091	66,512	67,443	71,670	72,429	71,081
Total Current Assets	45,383	46,448	44,657	44,292	45,539	47,531	47,640	47,970	52,252	53,341	51,741
Cash & Equivalents	2,233	2,916	2,774	4,678	2,636	2,524	1,982	4,583	2,302	2,509	1,131
Accounts Receivable	19,900	20,109	20,537	19,410	21,860	22,494	23,066	21,622	23,743	25,270	25,831
Inventories, net	19,505	19,876	20,657	19,691	20,510	21,945	22,020	21,139	25,571	24,176	23,837
Prepaid Expenses	590	722	675	513	533	568	572	626	636	751	942
Plant, Property, & Equipment, net	2,083	2,071	2,140	2,177	2,172	2,171	2,201	2,316	2,357	2,361	2,397
Total Noncurrent Assets	14,829	14,562	15,893	15,851	16,385	16,389	16,671	17,157	17,061	16,727	16,943
Goodwill	9,368	9,239	9,934	9,947	9,971	9,934	9,973	10,132	10,118	10,087	10,004
Intangible Assets	1,976	1,872	2,273	2,277	2,221	2,142	2,097	2,110	2,045	1,573	1,509
Other Noncurrent Operating Assets	3,485	3,451	3,686	3,627	4,193	4,313	4,601	4,915	4,898	5,067	5,430
Total Liabilities & Shareholders' Equity	62,295	63,081	62,690	62,320	64,096	66,091	66,512	67,443	71,670	72,429	71,081
Total Liabilities	63,767	64,330	64,779	63,810	65,336	67,555	68,194	69,042	73,051	75,071	73,785
Total Current Liabilities	47,201	48,357	48,006	47,957	48,422	51,147	51,661	52,357	56,434	58,771	58,562
Short-Term Debt	799	800	1,021	968	50	49	266	50	51	53	3,590
Accounts Payable	39,708	41,003	42,238	42,490	43,982	46,795	46,699	47,097	51,704	53,317	49,689
Accrued Expenses	4,077	4,279	4,453	4,200	4,090	4,007	4,400	4,915	4,383	4,787	5,027
Other Current Liabilities	293	284	292	299	300	296	296	295	296	243	256
Total Noncurrent Liabilities	16,566	15,973	16,773	15,853	16,914	16,408	16,533	16,685	16,617	16,300	15,223
Long-Term Debt	4,976	4,813	5,452	4,626	5,611	5,535	5,625	5,579	5,584	5,691	4,422
Asset Retirement Reserve & Litigation Obligation	7,132	6,644	6,642	6,625	6,628	6,128	6,128	6,113	6,114	5,617	5,617
Noncurrent Deferred & Payable Income Tax Liabilities	1,541	1,660	1,465	1,387	1,139	1,112	978	917	928	1,048	1,092
Other Noncurrent Operating Liabilities	2,917	2,856	3,214	3,215	3,536	3,633	3,802	4,076	3,991	3,944	4,092
Total Equity & Noncontrolling Interests	-1,472	-1,249	-2,089	-1,490	-1,240	-1,464	-1,682	-1,599	-1,381	-2,642	-2,704
Total Preferred & Common Equity	-2,004	-1,767	-2,455	-1,857	-1,602	-1,828	-2,053	-1,971	-1,755	-3,017	-3,084
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-2,004	-1,767	-2,455	-1,857	-1,602	-1,828	-2,053	-1,971	-1,755	-3,017	-3,084
Common Stock	7,353	7,612	7,539	7,750	7,827	7,902	7,965	8,051	8,129	8,224	8,294
Retained Earnings	9,732	10,579	11,582	12,295	13,182	13,761	14,268	14,978	15,810	15,959	16,752
Treasury Stock	-18,141	-18,844	-20,677	-20,997	-21,763	-22,604	-23,474	-24,119	-24,781	-26,310	-27,141
Accumulated Other Comprehensive Income / (Loss)	-948	-1,114	-899	-905	-848	-887	-812	-881	-913	-890	-989
Noncontrolling Interest	532	518	366	367	362	364	371	372	374	375	380

This table displays calculated financial ratios and metrics derived from McKesson's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2015	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	30.32%	6.61%	4.01%	4.95%	2.86%	7.81%	3.11%	10.80%	4.83%	11.65%
EBITDA Growth	26.26%	10.87%	80.68%	-80.33%	26.46%	69.71%	-214.81%	177.79%	79.46%	-14.76%
EBIT Growth	22.66%	18.87%	99.81%	-91.05%	65.84%	134.18%	-292.60%	147.69%	112.36%	-17.16%
NOPAT Growth	29.53%	24.15%	113.49%	-82.93%	-60.37%	564.05%	-244.01%	138.71%	158.08%	-7.51%
Net Income Growth	22.66%	49.71%	123.07%	-94.24%	-14.14%	339.22%	-487.50%	129.65%	189.20%	-15.10%
EPS Growth	15.90%	54.70%	134.33%	-98.59%	-46.88%	2,811.76%	-670.91%	125.58%	246.20%	-10.55%
Operating Cash Flow Growth	-0.77%	17.99%	29.19%	-8.41%	-7.11%	8.37%	3.84%	-2.38%	16.35%	-16.38%
Free Cash Flow Firm Growth	185.10%	-57.34%	175.06%	-60.35%	15.66%	30.45%	19.23%	-27.87%	68.30%	-33.61%
Invested Capital Growth	-16.42%	3.62%	-1.25%	-9.11%	-17.04%	-8.54%	-76.54%	-66.28%	-173.59%	3.66%
Revenue Q/Q Growth	4.13%	0.93%	1.04%	1.42%	0.38%	2.71%	0.26%	2.71%	1.03%	2.47%
EBITDA Q/Q Growth	18.19%	19.71%	133.29%	-76.94%	167.15%	273.69%	4.26%	-12.83%	6.19%	5.36%
EBIT Q/Q Growth	2.78%	1.26%	124.76%	-90.18%	145.52%	132.87%	3.70%	-14.55%	7.04%	6.29%
NOPAT Q/Q Growth	-0.13%	1.97%	138.64%	-82.68%	220.87%	232.99%	2.72%	-18.25%	14.83%	-0.13%
Net Income Q/Q Growth	-12.53%	14.93%	161.04%	-94.07%	396.51%	259.54%	-9.18%	-19.31%	12.75%	0.13%
EPS Q/Q Growth	-13.76%	15.89%	168.68%	-98.54%	113.71%	203.56%	-4.28%	-21.84%	14.66%	1.54%
Operating Cash Flow Q/Q Growth	-20.06%	49.94%	-26.05%	57.66%	27.52%	21.00%	-22.04%	-9.82%	9.28%	23.54%
Free Cash Flow Firm Q/Q Growth	223.34%	-37.53%	66.15%	-44.71%	529.04%	17.92%	-12.24%	-34.38%	37.14%	22.91%
Invested Capital Q/Q Growth	-14.92%	-7.48%	-1.68%	-18.15%	-28.89%	-24.38%	-52.14%	-62.61%	-135.92%	-124.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	6.37%	5.98%	5.68%	5.37%	5.48%	5.20%	5.10%	4.97%	4.47%	4.15%
EBITDA Margin	2.26%	2.35%	4.08%	0.77%	0.94%	1.48%	-1.65%	1.16%	1.98%	1.51%
Operating Margin	1.66%	1.86%	3.59%	0.37%	0.41%	1.08%	-2.12%	0.77%	1.58%	1.27%
EBIT Margin	1.69%	1.89%	3.63%	0.31%	0.50%	1.08%	-2.02%	0.87%	1.76%	1.31%
Profit (Net Income) Margin	0.86%	1.21%	2.60%	0.14%	0.12%	0.48%	-1.82%	0.49%	1.35%	1.02%
Tax Burden Percent	58.07%	71.08%	74.78%	124.27%	41.80%	97.90%	86.21%	66.75%	80.39%	83.40%
Interest Burden Percent	87.66%	90.20%	95.72%	37.11%	57.12%	45.74%	104.50%	83.94%	94.92%	93.76%
Effective Tax Rate	30.67%	27.94%	23.42%	-22.18%	58.36%	1.57%	0.00%	32.99%	19.55%	16.60%
Return on Invested Capital (ROIC)	13.41%	17.96%	37.90%	6.82%	3.10%	23.74%	-57.96%	88.31%	3,422.01%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	3.97%	12.25%	27.46%	-33.06%	-5.72%	-38.84%	-98.40%	83.73%	3,433.33%	0.00%
Return on Net Nonoperating Assets (RNNOA)	2.19%	5.28%	6.88%	-4.36%	-0.70%	-10.07%	-48.45%	-832.24%	-3,648.82%	0.00%
Return on Equity (ROE)	15.59%	23.23%	44.78%	2.46%	2.41%	13.67%	-106.41%	-743.93%	-226.81%	-204.60%
Cash Return on Invested Capital (CROIC)	31.29%	14.40%	39.16%	16.37%	21.73%	32.66%	66.03%	187.44%	0.00%	0.00%
Operating Return on Assets (OROA)	5.74%	6.53%	12.25%	1.06%	1.78%	4.14%	-7.63%	3.58%	7.77%	6.23%
Return on Assets (ROA)	2.92%	4.19%	8.77%	0.49%	0.42%	1.85%	-6.87%	2.01%	5.93%	4.87%
Return on Common Equity (ROCE)	13.02%	19.78%	38.95%	2.13%	2.03%	10.99%	-66.15%	-4,930.15%	-285.35%	-253.54%
Return on Equity Simple (ROE_SIMPLE)	19.29%	25.89%	46.44%	3.03%	3.15%	22.00%	0.00%	-56.65%	-200.43%	-160.32%
Net Operating Profit after Tax (NOPAT)	2,058	2,555	5,454	931	369	2,450	-3,528	1,366	3,525	3,260
NOPAT Margin	1.15%	1.34%	2.75%	0.45%	0.17%	1.06%	-1.48%	0.52%	1.27%	1.06%
Net Nonoperating Expense Percent (NNEP)	9.44%	5.71%	10.44%	39.89%	8.83%	62.58%	40.44%	4.58%	-11.31%	10.20%
Cost of Revenue to Revenue	93.63%	94.02%	94.32%	94.63%	94.52%	94.80%	94.90%	95.03%	95.53%	95.85%
SG&A Expenses to Revenue	4.41%	3.87%	3.75%	3.91%	3.94%	3.97%	3.71%	3.99%	2.81%	2.80%
R&D to Revenue	0.22%	0.21%	0.17%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.72%	4.12%	2.09%	5.00%	5.07%	4.13%	7.21%	4.20%	2.88%	2.89%
Earnings before Interest and Taxes (EBIT)	3,031	3,603	7,199	644	1,068	2,501	-4,817	2,297	4,878	4,041
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4,048	4,488	8,109	1,595	2,017	3,423	-3,930	3,057	5,486	4,676
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.11	3.76	2.67	2.81	2.66	4.56	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.27	0.18	0.15	0.13	0.10	0.10	0.13	0.17	0.18	0.23
Price to Earnings (P/E)	33.15	14.87	5.83	411.57	633.80	25.82	0.00	40.72	13.63	23.47
Dividend Yield	0.46%	0.74%	0.80%	0.97%	1.34%	1.23%	0.87%	0.60%	0.59%	0.33%
Earnings Yield	3.02%	6.72%	17.14%	0.24%	0.16%	3.87%	0.00%	2.46%	7.34%	4.26%
Enterprise Value to Invested Capital (EV/IC)	3.93	2.70	2.29	2.37	2.25	2.86	14.18	61.77	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.31	0.21	0.17	0.15	0.11	0.12	0.14	0.18	0.18	0.23
Enterprise Value to EBITDA (EV/EBITDA)	13.56	8.72	4.04	19.29	12.02	8.25	0.00	15.76	9.08	15.37
Enterprise Value to EBIT (EV/EBIT)	18.11	10.86	4.55	47.78	22.69	11.29	0.00	20.98	10.21	17.79
Enterprise Value to NOPAT (EV/NOPAT)	26.68	15.32	6.01	33.05	65.69	11.52	0.00	35.28	14.13	22.05
Enterprise Value to Operating Cash Flow (EV/OCF)	17.64	10.66	6.91	7.08	6.01	6.45	7.22	10.87	9.65	16.66
Enterprise Value to Free Cash Flow (EV/FCFF)	11.43	19.10	5.82	13.77	9.38	8.37	8.16	16.62	10.21	22.19
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.04	0.78	0.68	0.68	0.78	1.10	4.94	-3.28	-3.75	-3.52
Long-Term Debt to Equity	0.86	0.62	0.58	0.59	0.75	0.94	4.43	-2.83	-3.10	-3.49
Financial Leverage	0.55	0.43	0.25	0.13	0.12	0.26	0.49	-9.94	-1.06	-0.64
Leverage Ratio	5.34	5.55	5.11	5.03	5.66	7.38	15.48	-370.85	-38.27	-42.01
Compound Leverage Factor	4.68	5.01	4.89	1.87	3.24	3.37	16.18	-311.27	-36.33	-39.39
Debt to Total Capital	50.97%	43.79%	40.41%	40.63%	43.97%	52.40%	83.17%	143.85%	136.31%	139.68%
Short-Term Debt to Total Capital	8.62%	8.73%	5.86%	5.82%	1.91%	7.46%	8.63%	19.55%	23.59%	1.24%
Long-Term Debt to Total Capital	42.35%	35.07%	34.55%	34.81%	42.06%	44.94%	74.54%	124.30%	112.72%	138.44%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.61%	8.04%	7.12%	8.83%	9.18%	11.48%	17.07%	11.74%	8.94%	9.23%
Common Equity to Total Capital	41.42%	48.16%	52.47%	50.55%	46.85%	36.12%	-0.24%	-55.59%	-45.25%	-48.91%
Debt to EBITDA	2.43	1.81	1.05	4.94	3.77	2.16	-1.82	1.92	1.02	1.20
Net Debt to EBITDA	1.11	0.91	0.21	0.93	0.55	0.99	-0.22	0.77	0.17	0.22
Long-Term Debt to EBITDA	2.02	1.45	0.90	4.23	3.60	1.85	-1.63	1.66	0.84	1.19
Debt to NOPAT	4.78	3.18	1.57	8.46	20.59	3.02	-2.03	4.30	1.59	1.73
Net Debt to NOPAT	2.19	1.59	0.31	1.59	2.98	1.38	-0.25	1.72	0.26	0.32
Long-Term Debt to NOPAT	3.98	2.54	1.34	7.25	19.69	2.59	-1.82	3.72	1.31	1.71
Altman Z-Score	4.57	4.30	4.34	4.13	4.22	4.45	3.91	4.87	5.36	5.62
Noncontrolling Interest Sharing Ratio	16.50%	14.89%	13.01%	13.34%	15.56%	19.55%	37.83%	-562.72%	-25.81%	-23.92%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.09	1.10	1.04	1.01	1.02	0.99	1.03	0.95	0.92	0.92
Quick Ratio	0.63	0.63	0.59	0.56	0.56	0.56	0.58	0.46	0.50	0.50
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4,803	2,049	5,635	2,234	2,584	3,371	4,019	2,899	4,879	3,239
Operating Cash Flow to CapEx	827.66%	752.46%	1,174.26%	1,072.84%	947.42%	1,208.29%	1,007.10%	1,142.78%	1,322.82%	1,000.93%
Free Cash Flow to Firm to Interest Expense	12.84	5.80	18.30	5.52	9.79	13.54	18.52	7.86	19.67	12.85
Operating Cash Flow to Interest Expense	8.32	10.40	15.40	10.73	15.29	17.57	20.93	12.02	20.80	17.12
Operating Cash Flow Less CapEx to Interest Expense	7.32	9.02	14.09	9.73	13.67	16.11	18.85	10.96	19.23	15.41
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	3.39	3.46	3.38	3.43	3.57	3.82	3.77	4.11	4.41	4.76
Accounts Receivable Turnover	12.06	11.26	10.97	11.60	11.92	12.10	12.18	13.98	14.57	15.06
Inventory Turnover	12.29	12.11	12.23	12.48	12.27	13.10	12.57	13.22	13.77	14.51
Fixed Asset Turnover	84.44	88.31	86.89	87.62	85.52	94.06	96.33	112.98	129.64	137.53
Accounts Payable Turnover	7.24	6.68	6.28	6.24	6.14	6.17	5.94	6.51	6.56	6.61
Days Sales Outstanding (DSO)	30.27	32.41	33.27	31.47	30.62	30.17	29.98	26.11	25.06	24.24
Days Inventory Outstanding (DIO)	29.70	30.13	29.83	29.24	29.75	27.87	29.04	27.61	26.51	25.16
Days Payable Outstanding (DPO)	50.40	54.66	58.09	58.50	59.49	59.20	61.49	56.07	55.63	55.21
Cash Conversion Cycle (CCC)	9.57	7.88	5.02	2.21	0.88	-1.16	-2.47	-2.35	-4.06	-5.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	13,974	14,480	14,299	12,996	10,781	9,860	2,313	780	-574	-553
Invested Capital Turnover	11.67	13.42	13.80	15.27	18.03	22.39	39.14	170.69	2,686.51	-548.27
Increase / (Decrease) in Invested Capital	-2,745	506	-181	-1,303	-2,215	-921	-7,547	-1,533	-1,354	21
Enterprise Value (EV)	54,896	39,136	32,776	30,767	24,236	28,228	32,788	48,184	49,790	71,888
Market Capitalization	48,923	33,580	29,572	27,575	21,549	23,237	30,451	45,357	48,507	70,470
Book Value per Share	$34.36	$39.04	$52.32	$47.51	$42.19	$28.78	($0.13)	($15.17)	($13.56)	($15.00)
Tangible Book Value per Share	($22.58)	($16.99)	($14.88)	($25.31)	($25.82)	($41.96)	($77.86)	($92.00)	($102.83)	($108.16)
Total Capital	19,315	18,528	21,145	19,396	17,275	14,098	8,594	4,087	4,104	4,030
Total Debt	9,844	8,114	8,545	7,880	7,595	7,387	7,148	5,879	5,594	5,629
Total Long-Term Debt	8,180	6,497	7,305	6,751	7,265	6,335	6,406	5,080	4,626	5,579
Net Debt	4,503	4,066	1,699	1,480	1,101	3,372	870	2,347	916	1,046
Capital Expenditures (CapEx)	376	488	404	405	426	362	451	388	390	431
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-504	935	-207	-1,092	-1,812	-3,365	-4,257	-4,968	-7,375	-8,920
Debt-free Net Working Capital (DFNWC)	4,837	4,983	2,576	1,580	1,169	650	2,021	-1,436	-2,697	-4,337
Net Working Capital (NWC)	3,173	3,366	1,336	451	839	-402	1,279	-2,235	-3,665	-4,387
Net Nonoperating Expense (NNE)	515	245	301	634	114	1,330	812	79	-197	100
Net Nonoperating Obligations (NNO)	4,503	4,066	1,699	1,480	1,101	3,149	867	2,572	916	1,046
Total Depreciation and Amortization (D&A)	1,017	885	910	951	949	922	887	760	608	635
Debt-free, Cash-free Net Working Capital to Revenue	-0.28%	0.49%	-0.10%	-0.52%	-0.85%	-1.46%	-1.79%	-1.88%	-2.67%	-2.89%
Debt-free Net Working Capital to Revenue	2.70%	2.61%	1.30%	0.76%	0.55%	0.28%	0.85%	-0.54%	-0.97%	-1.40%
Net Working Capital to Revenue	1.77%	1.76%	0.67%	0.22%	0.39%	-0.17%	0.54%	-0.85%	-1.32%	-1.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$9.82	$22.95	$0.32	$0.17	$4.98	($28.26)	$7.32	$25.23	$22.54
Adjusted Weighted Average Basic Shares Outstanding	0.00	230M	221M	208M	196M	181M	160.60M	152.30M	141.10M	133.20M
Adjusted Diluted Earnings per Share	$0.00	$9.70	$22.73	$0.32	$0.17	$4.95	($28.26)	$7.23	$25.03	$22.39
Adjusted Weighted Average Diluted Shares Outstanding	0.00	233M	223M	209M	197M	182M	160.60M	154.10M	142.20M	134.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.17	$4.98	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	225.02M	210.90M	202.05M	189.96M	161.85M	158.19M	145.37M	135.60M	129.99M
Normalized Net Operating Profit after Tax (NOPAT)	2,162	2,701	5,690	2,045	2,322	2,796	2,309	1,738	3,686	3,479
Normalized NOPAT Margin	1.21%	1.41%	2.87%	0.98%	1.08%	1.21%	0.97%	0.66%	1.33%	1.13%
Pre Tax Income Margin	1.48%	1.70%	3.47%	0.11%	0.28%	0.50%	-2.11%	0.73%	1.67%	1.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.10	10.21	23.37	1.59	4.05	10.04	-22.20	6.22	19.67	16.04
NOPAT to Interest Expense	5.50	7.24	17.71	2.30	1.40	9.84	-16.26	3.70	14.21	12.94
EBIT Less CapEx to Interest Expense	7.10	8.82	22.06	0.59	2.43	8.59	-24.28	5.17	18.10	14.33
NOPAT Less CapEx to Interest Expense	4.50	5.85	16.40	1.30	-0.22	8.38	-18.34	2.65	12.64	11.23
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	14.71%	10.56%	4.91%	88.22%	114.51%	26.25%	-6.36%	21.52%	7.85%	9.94%
Augmented Payout Ratio	43.88%	80.35%	49.76%	663.64%	757.25%	199.20%	-24.59%	374.83%	105.59%	105.66%

This table displays calculated financial ratios and metrics derived from McKesson's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.15%	5.38%	2.73%	4.25%	10.91%	10.06%	14.77%	10.80%	6.44%	21.29%	17.80%
EBITDA Growth	44.63%	66.09%	231.01%	37.56%	8.17%	-21.79%	-49.85%	20.31%	2.39%	-31.66%	73.17%
EBIT Growth	72.01%	91.59%	377.04%	46.52%	8.28%	-24.79%	-55.44%	23.64%	1.85%	-37.36%	91.27%
NOPAT Growth	53.41%	132.56%	2,185.77%	118.12%	20.96%	-16.98%	-31.09%	-0.68%	-9.34%	-57.44%	40.19%
Net Income Growth	51.78%	211.94%	2,771.79%	103.95%	23.24%	-27.30%	-43.75%	0.48%	-3.71%	-59.18%	47.30%
EPS Growth	71.34%	275.44%	19,250.00%	128.51%	33.46%	-23.36%	-42.30%	5.98%	-0.28%	-61.99%	57.24%
Operating Cash Flow Growth	41.99%	-38.23%	21.13%	15.17%	-11.80%	-12.83%	-84.77%	24.72%	-31.18%	117.62%	-1,038.19%
Free Cash Flow Firm Growth	-41.79%	-63.56%	-48.12%	15.09%	-89.33%	-107.73%	-97.80%	-62.13%	62.08%	725.71%	-3,310.28%
Invested Capital Growth	-73.71%	-79.52%	-23.39%	-173.59%	44.07%	159.93%	39.36%	3.66%	9.36%	-79.39%	87.56%
Revenue Q/Q Growth	1.59%	4.47%	0.47%	-2.24%	8.09%	3.67%	4.77%	-5.62%	3.83%	18.12%	1.75%
EBITDA Q/Q Growth	40.73%	20.93%	14.83%	-29.61%	10.67%	-12.57%	-26.37%	68.86%	-5.82%	-41.64%	86.58%
EBIT Q/Q Growth	52.32%	23.60%	16.78%	-33.36%	12.56%	-14.15%	-30.81%	84.91%	-7.28%	-47.20%	111.27%
NOPAT Q/Q Growth	108.71%	5.78%	9.09%	-9.44%	15.74%	-27.39%	-9.45%	30.53%	5.64%	-65.91%	198.24%
Net Income Q/Q Growth	99.75%	19.53%	15.82%	-26.25%	20.70%	-29.49%	-10.38%	31.75%	15.66%	-70.10%	223.34%
EPS Q/Q Growth	111.25%	22.05%	19.31%	-25.72%	23.37%	-29.91%	-10.16%	36.43%	16.09%	-73.29%	271.66%
Operating Cash Flow Q/Q Growth	-132.59%	217.64%	50.68%	99.34%	-131.64%	191.73%	-73.68%	1,532.68%	-133.28%	252.17%	-213.48%
Free Cash Flow Firm Q/Q Growth	122.92%	-24.20%	-55.66%	53.59%	-79.34%	-154.91%	112.64%	2,539.81%	-11.57%	111.97%	-164.88%
Invested Capital Q/Q Growth	58.85%	-50.44%	160.26%	-135.92%	410.98%	-10.59%	39.54%	-124.83%	452.98%	-83.15%	1,169.60%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	4.50%	4.41%	4.50%	4.45%	4.06%	3.97%	3.90%	4.70%	3.98%	3.47%	3.45%
EBITDA Margin	1.79%	2.07%	2.36%	1.70%	1.74%	1.47%	1.03%	1.85%	1.68%	0.83%	1.52%
Operating Margin	1.54%	1.60%	1.76%	1.42%	1.48%	1.23%	0.79%	1.59%	1.30%	0.62%	1.28%
EBIT Margin	1.57%	1.85%	2.15%	1.47%	1.53%	1.27%	0.84%	1.64%	1.46%	0.65%	1.36%
Profit (Net Income) Margin	1.20%	1.38%	1.59%	1.20%	1.34%	0.91%	0.78%	1.09%	1.21%	0.31%	0.97%
Tax Burden Percent	80.42%	77.73%	77.35%	88.63%	91.38%	76.75%	102.94%	70.94%	88.56%	53.75%	75.69%
Interest Burden Percent	95.72%	95.77%	95.45%	92.19%	95.87%	93.76%	90.53%	93.60%	93.53%	87.25%	94.82%
Effective Tax Rate	19.78%	21.78%	22.72%	11.37%	8.62%	23.25%	-2.94%	29.06%	11.44%	46.25%	24.31%
Return on Invested Capital (ROIC)	111.63%	188.75%	202.31%	3,386.08%	253.53%	249.01%	128.79%	0.00%	193.01%	113.79%	104.63%
ROIC Less NNEP Spread (ROIC-NNEP)	111.04%	192.30%	207.22%	3,383.64%	253.25%	247.92%	127.98%	0.00%	194.54%	113.01%	104.66%
Return on Net Nonoperating Assets (RNNOA)	-548.73%	-712.20%	-472.65%	-3,596.02%	-535.63%	-449.87%	-257.79%	0.00%	-471.91%	-165.99%	-257.46%
Return on Equity (ROE)	-437.10%	-523.45%	-270.34%	-209.94%	-282.09%	-200.86%	-129.00%	-204.60%	-278.90%	-52.20%	-152.84%
Cash Return on Invested Capital (CROIC)	172.22%	252.04%	193.13%	0.00%	207.99%	232.35%	137.80%	0.00%	160.68%	418.26%	33.72%
Operating Return on Assets (OROA)	6.71%	7.95%	9.33%	6.46%	6.87%	5.70%	3.90%	7.80%	6.76%	3.12%	6.80%
Return on Assets (ROA)	5.17%	5.92%	6.89%	5.28%	6.02%	4.10%	3.63%	5.18%	5.60%	1.46%	4.88%
Return on Common Equity (ROCE)	-733.23%	-916.04%	-350.52%	-264.12%	-375.08%	-266.16%	-154.21%	-253.54%	-357.22%	-61.59%	-179.01%
Return on Equity Simple (ROE_SIMPLE)	-77.99%	-125.64%	-134.46%	0.00%	-244.07%	-199.45%	-153.73%	0.00%	-177.95%	-89.72%	-97.44%
Net Operating Profit after Tax (NOPAT)	831	879	959	869	1,005	730	661	863	911	311	926
NOPAT Margin	1.24%	1.25%	1.36%	1.26%	1.35%	0.95%	0.82%	1.13%	1.15%	0.33%	0.97%
Net Nonoperating Expense Percent (NNEP)	0.59%	-3.55%	-4.91%	2.44%	0.29%	1.09%	0.81%	3.33%	-1.53%	0.78%	-0.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	15.70%	-	-	-	17.45%
Cost of Revenue to Revenue	95.50%	95.59%	95.50%	95.55%	95.94%	96.03%	96.10%	95.30%	96.02%	96.53%	96.55%
SG&A Expenses to Revenue	2.92%	2.78%	2.70%	2.85%	2.51%	2.71%	3.10%	2.87%	2.52%	2.67%	2.13%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.96%	2.81%	2.74%	3.03%	2.58%	2.74%	3.10%	3.10%	2.68%	2.85%	2.16%
Earnings before Interest and Taxes (EBIT)	1,051	1,299	1,517	1,011	1,138	977	676	1,250	1,159	612	1,293
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,199	1,450	1,665	1,172	1,297	1,134	835	1,410	1,328	775	1,446
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.18	0.18	0.19	0.18	0.20	0.20	0.20	0.23	0.24	0.19	0.21
Price to Earnings (P/E)	33.64	23.58	16.82	13.63	15.39	16.76	20.45	23.47	25.66	25.28	25.60
Dividend Yield	0.58%	0.58%	0.54%	0.59%	0.51%	0.52%	0.49%	0.33%	0.32%	0.39%	0.47%
Earnings Yield	2.97%	4.24%	5.94%	7.34%	6.50%	5.97%	4.89%	4.26%	3.90%	3.96%	3.91%
Enterprise Value to Invested Capital (EV/IC)	41.20	84.16	35.61	0.00	34.24	38.77	29.46	0.00	40.79	205.85	19.06
Enterprise Value to Revenue (EV/Rev)	0.19	0.19	0.21	0.18	0.22	0.21	0.22	0.23	0.25	0.21	0.23
Enterprise Value to EBITDA (EV/EBITDA)	14.89	12.90	11.01	9.08	10.94	11.75	14.78	15.37	16.92	15.58	16.05
Enterprise Value to EBIT (EV/EBIT)	18.65	15.39	12.49	10.21	12.31	13.33	17.25	17.79	19.60	18.32	18.45
Enterprise Value to NOPAT (EV/NOPAT)	30.91	23.84	18.54	14.13	16.56	17.43	20.09	22.05	25.12	24.55	26.28
Enterprise Value to Operating Cash Flow (EV/OCF)	9.98	11.66	12.05	9.65	12.11	12.61	18.79	16.66	19.98	13.22	32.05
Enterprise Value to Free Cash Flow (EV/FCFF)	9.96	11.35	16.00	10.21	19.43	24.10	24.89	22.19	26.52	16.82	73.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-3.92	-4.49	-3.10	-3.75	-4.57	-3.81	-3.50	-3.52	-4.08	-2.17	-2.96
Long-Term Debt to Equity	-3.38	-3.85	-2.61	-3.10	-4.53	-3.78	-3.34	-3.49	-4.04	-2.15	-1.64
Financial Leverage	-4.94	-3.70	-2.28	-1.06	-2.12	-1.81	-2.01	-0.64	-2.43	-1.47	-2.46
Leverage Ratio	-82.91	-94.82	-43.95	-38.27	-46.60	-47.61	-34.26	-42.01	-51.80	-33.74	-31.37
Compound Leverage Factor	-79.36	-90.81	-41.95	-35.28	-44.68	-44.64	-31.02	-39.32	-48.45	-29.44	-29.75
Debt to Total Capital	134.21%	128.62%	147.65%	136.31%	128.05%	135.53%	139.96%	139.68%	132.46%	185.17%	150.94%
Short-Term Debt to Total Capital	18.57%	18.33%	23.29%	23.59%	1.13%	1.19%	6.32%	1.24%	1.20%	1.71%	67.63%
Long-Term Debt to Total Capital	115.64%	110.29%	124.36%	112.72%	126.92%	134.34%	133.64%	138.44%	131.26%	183.46%	83.31%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	12.36%	11.87%	8.35%	8.94%	8.19%	8.84%	8.81%	9.23%	8.79%	12.09%	7.16%
Common Equity to Total Capital	-46.57%	-40.49%	-56.00%	-45.25%	-36.24%	-44.37%	-48.78%	-48.91%	-41.26%	-97.26%	-58.10%
Debt to EBITDA	1.69	1.40	1.25	1.02	1.01	1.06	1.33	1.20	1.20	1.32	1.62
Net Debt to EBITDA	1.03	0.67	0.72	0.17	0.54	0.58	0.88	0.22	0.71	0.74	1.39
Long-Term Debt to EBITDA	1.45	1.20	1.06	0.84	1.00	1.05	1.27	1.19	1.19	1.31	0.89
Debt to NOPAT	3.50	2.59	2.11	1.59	1.53	1.57	1.80	1.73	1.78	2.08	2.64
Net Debt to NOPAT	2.15	1.24	1.21	0.26	0.82	0.86	1.20	0.32	1.05	1.17	2.27
Long-Term Debt to NOPAT	3.01	2.22	1.78	1.31	1.52	1.56	1.72	1.71	1.76	2.06	1.46
Altman Z-Score	4.99	5.03	5.13	5.16	5.25	5.20	5.33	5.49	5.29	5.32	5.71
Noncontrolling Interest Sharing Ratio	-67.75%	-75.00%	-29.66%	-25.81%	-32.96%	-32.51%	-19.54%	-23.92%	-28.08%	-18.00%	-17.12%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.96	0.96	0.93	0.92	0.94	0.93	0.92	0.92	0.93	0.91	0.88
Quick Ratio	0.47	0.48	0.49	0.50	0.51	0.49	0.48	0.50	0.46	0.47	0.46
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4,305	3,263	1,447	2,223	459	-252	32	842	744	1,578	-1,024
Operating Cash Flow to CapEx	-1,325.35%	1,287.21%	1,544.44%	2,660.00%	-1,348.72%	1,286.67%	282.22%	2,205.85%	-1,301.89%	1,544.12%	-1,891.27%
Free Cash Flow to Firm to Interest Expense	95.67	59.33	20.97	28.13	9.77	-4.13	0.50	10.52	9.92	20.23	-15.28
Operating Cash Flow to Interest Expense	-20.91	20.13	24.17	42.09	-22.38	15.82	3.97	51.84	-18.40	26.92	-35.57
Operating Cash Flow Less CapEx to Interest Expense	-22.49	18.56	22.61	40.51	-24.04	14.59	2.56	49.49	-19.81	25.18	-37.45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	4.29	4.29	4.33	4.41	4.49	4.51	4.67	4.76	4.62	4.77	5.01
Accounts Receivable Turnover	13.39	13.52	14.09	14.57	13.60	13.67	13.83	15.06	13.76	13.83	14.09
Inventory Turnover	12.92	13.22	13.17	13.77	13.58	13.33	13.55	14.51	13.06	13.75	14.45
Fixed Asset Turnover	115.91	126.73	130.31	129.64	133.51	137.25	138.91	137.53	138.55	145.71	149.88
Accounts Payable Turnover	6.54	6.49	6.58	6.56	6.49	6.35	6.50	6.61	6.29	6.33	6.87
Days Sales Outstanding (DSO)	27.26	27.00	25.91	25.06	26.83	26.71	26.39	24.24	26.53	26.40	25.90
Days Inventory Outstanding (DIO)	28.25	27.62	27.72	26.51	26.88	27.38	26.93	25.16	27.96	26.55	25.26
Days Payable Outstanding (DPO)	55.82	56.28	55.47	55.63	56.22	57.48	56.12	55.21	58.06	57.63	53.09
Cash Conversion Cycle (CCC)	-0.31	-1.66	-1.84	-4.06	-2.51	-3.39	-2.80	-5.81	-3.57	-4.68	-1.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,239	614	1,598	-574	1,785	1,596	2,227	-553	1,952	329	4,177
Invested Capital Turnover	90.20	150.62	148.70	2,686.51	187.86	263.44	157.65	-548.27	167.92	343.05	107.61
Increase / (Decrease) in Invested Capital	-3,474	-2,384	-488	-1,354	546	982	629	21	167	-1,267	1,950
Enterprise Value (EV)	51,042	51,671	56,901	49,790	61,115	61,878	65,598	71,888	79,624	67,725	79,605
Market Capitalization	46,968	48,456	52,836	48,507	57,728	58,454	61,318	70,470	75,917	64,115	72,344
Book Value per Share	($13.79)	($12.29)	($17.31)	($13.56)	($11.81)	($13.55)	($15.43)	($15.00)	($13.50)	($23.27)	($24.29)
Tangible Book Value per Share	($91.82)	($89.60)	($103.40)	($102.83)	($101.72)	($103.07)	($106.14)	($108.16)	($107.07)	($113.18)	($114.99)
Total Capital	4,303	4,364	4,384	4,104	4,421	4,120	4,209	4,030	4,254	3,102	5,308
Total Debt	5,775	5,613	6,473	5,594	5,661	5,584	5,891	5,629	5,635	5,744	8,012
Total Long-Term Debt	4,976	4,813	5,452	4,626	5,611	5,535	5,625	5,579	5,584	5,691	4,422
Net Debt	3,542	2,697	3,699	916	3,025	3,060	3,909	1,046	3,333	3,235	6,881
Capital Expenditures (CapEx)	71	86	108	125	78	75	90	188	106	136	126
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3,252	-4,025	-5,102	-7,375	-5,469	-6,091	-5,737	-8,920	-6,433	-7,886	-4,362
Debt-free Net Working Capital (DFNWC)	-1,019	-1,109	-2,328	-2,697	-2,833	-3,567	-3,755	-4,337	-4,131	-5,377	-3,231
Net Working Capital (NWC)	-1,818	-1,909	-3,349	-3,665	-2,883	-3,616	-4,021	-4,387	-4,182	-5,430	-6,821
Net Nonoperating Expense (NNE)	22	-88	-161	43	8.22	27	31	33	-49	24	-1.51
Net Nonoperating Obligations (NNO)	2,711	1,863	3,687	916	3,025	3,060	3,909	1,046	3,333	2,971	6,881
Total Depreciation and Amortization (D&A)	148	151	148	161	159	157	159	160	169	163	153
Debt-free, Cash-free Net Working Capital to Revenue	-1.21%	-1.48%	-1.86%	-2.67%	-1.93%	-2.09%	-1.90%	-2.89%	-2.05%	-2.39%	-1.27%
Debt-free Net Working Capital to Revenue	-0.38%	-0.41%	-0.85%	-0.97%	-1.00%	-1.23%	-1.25%	-1.40%	-1.32%	-1.63%	-0.94%
Net Working Capital to Revenue	-0.68%	-0.70%	-1.22%	-1.32%	-1.02%	-1.24%	-1.33%	-1.42%	-1.33%	-1.64%	-1.98%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.32	$6.47	$7.71	$5.73	$7.07	$4.95	$4.45	$6.07	$7.04	$1.88	$6.98
Adjusted Weighted Average Basic Shares Outstanding	144.20M	143.10M	139.90M	141.10M	135.50M	134.10M	132.50M	133.20M	129.80M	128.70M	126M
Adjusted Diluted Earnings per Share	$5.26	$6.42	$7.66	$5.69	$7.02	$4.92	$4.42	$6.03	$7.00	$1.87	$6.95
Adjusted Weighted Average Diluted Shares Outstanding	145.90M	144.10M	141M	142.20M	136.60M	134.80M	133.30M	134.10M	130.70M	129.30M	126.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	143.73M	141.79M	136.94M	135.60M	134.90M	133.06M	131.41M	129.99M	129.68M	126.94M	125.33M
Normalized Net Operating Profit after Tax (NOPAT)	854	896	982	977	1,053	750	452	990	1,019	400	951
Normalized NOPAT Margin	1.27%	1.28%	1.39%	1.42%	1.41%	0.97%	0.56%	1.30%	1.29%	0.43%	1.00%
Pre Tax Income Margin	1.50%	1.77%	2.05%	1.35%	1.46%	1.19%	0.76%	1.53%	1.37%	0.57%	1.29%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	23.36	23.62	21.99	12.80	24.21	16.02	10.56	15.63	15.45	7.85	19.30
NOPAT to Interest Expense	18.47	15.98	13.90	10.99	21.39	11.96	10.33	10.78	12.15	3.98	13.83
EBIT Less CapEx to Interest Expense	21.78	22.05	20.42	11.22	22.55	14.79	9.16	13.28	14.04	6.10	17.42
NOPAT Less CapEx to Interest Expense	16.89	14.42	12.33	9.41	19.73	10.74	8.92	8.43	10.74	2.24	11.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	17.85%	12.70%	8.69%	7.85%	7.54%	8.28%	9.76%	9.94%	10.31%	12.08%	11.18%
Augmented Payout Ratio	242.29%	180.63%	161.07%	105.59%	92.81%	108.64%	88.50%	105.66%	101.76%	142.81%	128.45%

Key Financial Trends

Over the past four quarters, McKesson has delivered strong revenue growth, driven by higher pharmaceutical distribution volumes and back‐end services. However, operating cash flow has been volatile, and free cash flow to firm turned negative in Q3 2025 as working capital needs spiked. The company continues to deploy capital for share repurchases but has also raised significant new debt, pushing net leverage higher.

Revenue growth accelerated to 17.8% year-over-year in Q3 2025, reflecting strong demand and pricing initiatives.
Executed $827 million in share repurchases in Q3 2025, supporting EPS and returning capital to shareholders.
Gross margin remained steady at about 3.4% in Q3 2025, in line with historical levels.
SG&A expenses were 2.13% of revenue in Q3 2025, slightly lower than a year earlier.
Free cash flow to firm was negative $1.02 billion in Q3 2025, driven by working capital outflows.
Net debt rose to $6.88 billion in Q3 2025, up from $3.24 billion in Q2, increasing leverage.
Current ratio stood at 0.88x in Q3 2025, indicating tight short-term liquidity.
Return on invested capital (ROIC) was just 1.05% in Q3 2025, below typical cost of capital.
Total shareholders’ equity was negative $2.7 billion as of Q3 2025, due to large treasury stock balances.
Operating cash flow swung to a $2.38 billion outflow in Q3 2025, versus inflows in prior quarters.

06/22/25 06:36 AMAI Generated. May Contain Errors.

Frequently Asked Questions About McKesson's Financials

When does McKesson's fiscal year end?

According to the most recent income statement we have on file, McKesson's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has McKesson's net income changed over the last 9 years?

McKesson's net income appears to be on a downward trend, with a most recent value of $3.16 billion in 2024, rising from $1.54 billion in 2015. The previous period was $3.72 billion in 2023. See where experts think McKesson is headed by visiting McKesson's forecast page.

What is McKesson's operating income?

McKesson's total operating income in 2024 was $3.91 billion, based on the following breakdown:

Total Gross Profit: $12.83 billion
Total Operating Expenses: $8.92 billion

How has McKesson's revenue changed over the last 9 years?

Over the last 9 years, McKesson's total revenue changed from $179.05 billion in 2015 to $308.95 billion in 2024, a change of 72.6%.

How much debt does McKesson have?

McKesson's total liabilities were at $69.04 billion at the end of 2024, a 8.2% increase from 2023, and a 55.5% increase since 2015.

How much cash does McKesson have?

In the past 9 years, McKesson's cash and equivalents has ranged from $2.67 billion in 2018 to $6.28 billion in 2021, and is currently $4.58 billion as of their latest financial filing in 2024.

How has McKesson's book value per share changed over the last 9 years?

Over the last 9 years, McKesson's book value per share changed from 34.36 in 2015 to -15.00 in 2024, a change of -143.7%.

Related Companies

This page (NYSE:MCK) was last updated on 6/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Financials

Key Financial Trends

Frequently Asked Questions About McKesson's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Financials

Annual Income Statements for McKesson

Quarterly Income Statements for McKesson

Annual Cash Flow Statements for McKesson

Quarterly Cash Flow Statements for McKesson

Annual Balance Sheets for McKesson

Quarterly Balance Sheets for McKesson

Annual Metrics And Ratios for McKesson

Quarterly Metrics And Ratios for McKesson

Key Financial Trends

Frequently Asked Questions About McKesson's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools